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ABSTRACT
It was hypothesised that increased exercise capacity is related to improved quality of life (QoL) in patients with
cystic fibrosis (CF). A 12-week individually tailored unsupervised aerobic exercise programme was offered to
42 patients with CF. At the start and at the end of the exercise programme, data on QoL, current exercise habits
and preferences, anthropometric data, exercise test, and lung function test were collected. Adherence was
observed by a heart rate (HR) monitor. A total of 24 patients accepted to be enrolled in the exercise programme
and 14 completed the programme. Another 14 patients declined to be enrolled in the exercise programme but
completed the Cystic Fibrosis Questionnaire for Adolescents and Adults (CFQ-R 14+). Four patients did not
want to participate at all. The 14 patients completing the exercise programme had a significantly increased
VO2max, but they showed no significant change in total QoL score. However, the scores in the domain of treat-
ment burden and emotional functioning increased significantly. There was no significant difference in QoL and
lung function between patients participating in the exercise programme (n=24) and non-participants (n=14).
A 12-week individually tailored unsupervised aerobic exercise programme where HR monitors were used signifi-
cantly affected VO2max. Improvement in QoL could not be demonstrated in this study.
INTRODUCTION
Cystic fibrosis (CF) is the most common hereditary
disease in Caucasians, and no curative treatment has
yet been found. In Denmark, life expectancy is now
a median of 42 years (Ravilly et al, 2005).
Approximately 1 in 4,700 (Watters and Mehta,
2007) live births in Denmark is affected by the con-
dition, and there are approximately 420 patients with
CF in Denmark. CF primarily affects lung function
and nutritional status (Klijn et al, 2003).
Duringthelastdecade,focushasbeenonexerciseas
an important element in the treatment of CF. Exercise
hasthusbeenincorporatedinmanystandardtreatment
regimes, and exercise capacity is more often used as an
outcome variable in intervention studies. Exercise
capacity is currently used as an important parameter
of disease status and progression (Orenstein and
Higgins, 2005; Schneidermann-Walker et al, 2000;
Turchetta, 2004), and it is well known that patients
with a high exercise capacity have a longer life expect-
ancy (Hebestreit et al, 2006; Klijn et al, 2004; Oren-
stein et al, 2004). Furthermore, it has been stated that
aerobic capacity correlates with quality of life (QoL)
measures, and changes in the former are associated
with changes in the latter (Hebestreit et al, 2006).
Therefore, we designed a 12-week intervention study
consisting of an individually tailored and unsupervised
aerobic exercise programme to investigate the associ-
ation between increased exercise capacity and changes
in QoL in patients with CF. The exercise programme
comprised everyday life activities adapted to the
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548preferences of each individual patient. The patient was
personally responsible for activating an HR monitor for
every exercise session, indicating intensity, frequency,
and duration and thus adherence to the programme.
It is our clinical experience that it can be difficult to
motivate patients with CF to incorporate regular exer-
ciseintotheireverydaylife.QoLispotentiallynegatively
affected by the large burden of treatment and the com-
plexity of the treatment evolving over years as CF pro-
gresses (Gee et al, 2005). It was our hope that an
increaseinexercisecapacityandtherebyanexperienced
increaseinQoLcouldmotivatethepatientstoadhereto
the unsupervised exercise programme.
It was hypothesised that a 12-week individually tai-
lored and unsupervised aerobic exercise programme




Patients from the CF Centre at Aarhus University
Hospital, Skejby, between 14 and 50 years of age,
were invited. In our CF registry we found 42 eligible
patients, and 24 accepted to participate in the study.
A total of 14 of the 18 patients who declined partici-
pation filled in the Cystic Fibrosis Questionnaire for
Adolescents and Adults (CFQ-R 14+).
Exclusion criteria were FEV1% <60, lung trans-
plantation, debut of asthma or diabetes in the inter-
vention period, and/or physical or psychological
disability preventing participation.
All patients attended the CF Centre regularly, and
during the study period the patients continued their
regular therapy, including airway clearance therapy
using a positive expiratory pressure mask, enzymes,
vitamins, and other medical treatment.
Written informed consent was obtained from
patients or parents. The study was approved by the
Central Denmark Region Committees on Biomedical
and Research Ethics, file number 20060052.
Study design
The study period was 12 weeks. Measurements were
performed at the start and at the end of the study.
The pretests and posttests were identical.
Measurements
Measurements were performed by the same assessors
involved in the delivery of the intervention, and the
patients were initially acquainted with the test
procedures.
Quality of life
QoL was measured by using the Danish validated
version (Bregnballe et al, 2008) of the disease-specific
health-related QoL questionnaire, CFQ-R 14+
(Quittner et al, 2000). With a Chronbach’s α
ranging from 0.54 to 0.95, this seemed to be a reliable
and valid instrument for measuring CF specific QoL
(Bregnballe et al, 2008).
The CFQ-R 14+ consists of 49 self-reported items
within 12 domains: 1) physical functioning (8 items);
2) vitality (4 items); 3) emotional functioning (5
items); 4) eating disturbances (3 items); 5) treatment
burden (3 items); 6) general health perception (3
items); 7) social functioning (6 items); 8) body image
(3 items); 9) role limitations (4 items); 10) weight pro-
blems (1 item); 11) respiratory symptoms (6 items);
and12)digestivesymptoms(3items).Answerswerere-
portedonafour-pointscaleratingfrequency,difficulty,
or truth, and selecting one of four statements that de-
scribed the patient’s situation. The scores ranged
from 0 to100 and higher scores equalled higher QoL.
Current exercise habits and preferences
To assess the patients’ level of current physical
activity, we asked them to fill in a short questionnaire
(Wilhelmsen, Tibblin, Fordor, and Werkö, 1971).
Furthermore, we interviewed the patients about their
preferred physical activity.
Anthropometric data
Body weight was measured by using an electronic
calibrated kilogram scale (BWB-800MA, Titan Cor-
poration, Netherlands) and standing height using a
stadiometer. The measurements were used to calcu-
late the body mass index (BMI). For comparison
between the different age groups, a BMI z score was
calculated on the basis of Danish data on children
and adults (Nysom, Mølgaard, Hutchings, and
Michaelson, 2001).
Exercise test and maximum heart rate
Exercise capacity was measured as peak oxygen con-
sumption rate (L/min). Before starting the incremen-
tal maximum exercise test, the patients warmed up
on a voluntary level for 5 minutes on the cycle erg-
ometer (Monark, Ergomedic 828E, Sweden). To
reach the patients’ maximum in 5–10 minutes, step-
wise increments of 0.4 kilopond (kp) every 1.5
minutes were made, starting on individual levels
from 0.8 to 1.8 kp, depending on the physical fitness
of the patient. The patients were asked to choose a
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and to keep it during the test. The maximum level
was reached when the patient could no longer main-
tain the cadence or to volitional fatigue. Patients
were verbally encouraged throughout the test. The
patients wore a close-fitting mask connected to an
online respiratory gas exchange analyser (AMIS
2001, Innovision, Denmark) and computer system.
Expired air was sampled continuously, and oxygen
consumption and carbon dioxide production were
measured every 10 seconds. VO2max was determined
as the peak oxygen uptake every 10 seconds through-
out the test. VO2max was normalised to body mass
(VO2max/kg). The HR was monitored (Polar, RS400,
Finland) continuously every 5 seconds during the
test, and the highest value was recorded. After the
test, efforts were considered to be at a maximum
level when three of the following four criteria were
met: 1) total exhaustion; 2) HR above (220 - age) -
10% 3) respiratory exchange ratio (the ratio between
the measurements of VCO2 and VO2) above 1.11;
and 4) the VO2 curve levelled off with a surge of less
than 0.15 L/min from the last increment until the
patient stopped the test.
Lung function
FEV1% was performed by using a Pneumotach spi-
rometer (Masterscreen Body, Jäger, Germany). The
pretest on lung function was performed on the day
the patient entered the study, and the posttest on
lung function was performed the day the patient
ended the study.
Intervention
To optimise adherence, each patient had the opportu-
nity to select one or more physical activities for their
individually tailored exercise programme. The
patients chose different activities such as bicycling (in-
cluding exercise bike), running, gymnastics, swim-
ming, and dancing. Some patients performed more
than one activity.
The patients were instructed to exercise at least half
an hour three times a week for 12 weeks with an HR
above 70% of their maximum HR calculated from
the maximum HR of the pretest. An intensity of
70% of maximum HR has been used in several
studies on patients with CF where an improvement
in VO2max was obtained (de Jong et al, 1994;
Gulmans et al, 1999; Schneidermann-Walker et al,
2000; Selvadurai et al, 2002).
The exercise programme was intended to be a sup-
plement to any exercise the patient already did.
Each training session was divided into two phases:
1) a warm-up phase of 5 minutes and 2) a training
phase of at least 25 minutes. If the patients could
not endure intensity above 70% of their HR
maximum, they were allowed to stop the HR
monitor and have a short break. HR was continuously
monitored every 5 seconds by an HR monitor (Polar,
RS400, Finland) to control training intensity. Exercise
data were stored in the HR monitor as an exercise
dairy and an evidence of adherence.
The patients were offered supervised training at the
CF Centre once every second week, but no patients
accepted this offer. We made motivational phone
calls to all patients every week in the beginning of
the exercise programme, and subsequent follow-up
was planned individually. The motivational phone
calls followed a nonstandardised semistructured inter-
view guide. After the posttest exercise, data were trans-
ferred to a computer for analysis.
Statistical analysis
Pretest values for different groups were analysed by a
Mann-Whitney test. Dichotomous variables were
tested by a chi-square test. Pretest and posttest values
were compared by using a paired t test. A p-value of ≤
0.05 was considered statistically significant. AWilcoxin
signed-ranks test was conducted to evaluate the impact
of the exercise programme on CFQ-R14+ scores. By a
Kruskal-Wallis test, CFQ-R 14+ scores of group 1
were compared with the CFQ-R 14+ scores of group 0
before starting the exercise programme and with group
2 (see classification of groups in Results).
RESULTS
Baseline data
The patients were classified as follows: group 0 =
dropouts from the exercise programme (n= 10);
group 1 = patients completing the exercise programme
(n= 14); and group 2= patients only filling in the
CFQ-R 14+, non-participants (n= 14). Clinical
characteristics of the 24 patients in the exercise pro-
gramme (groups 0+ 1) are shown in Table 1.
Ten (group 0) of the 24 patients did not complete
the exercise programme mainly due to practical
reasons (e.g., lack of time and/or motivation and one
patient had a knee injury at work). These 10 patients
were not posttested. Fourteen (group 1) of the 24
patients were pretested, completed the exercise pro-
gramme, and were posttested.
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pleting the exercise programme (group 1) did on
average not meet the intended frequencyand duration.
Frequency was on average 2.31 times aweek instead of
three times a week, and duration was on average 79
minutes a week instead of 90 minutes a week. The
patient exercising with the lowest intensity exercised
with a 75% of maximum HR on average, and the
patient exercising with the highest intensity exercised
with an 86% of maximum HR on average (both
patients, lowest and highest) exercising more than the
recommended 70% of maximum HR. As shown in
Table 2, we found no significant differences between
group0andgroup1concerningphysicalbaselinedata.
Fourteen (group 2) of 18 patients filled in the
CFQ-R14+ but did not participate in the exercise pro-
gramme. As shown in Table 3, no significant differ-
ence ( p= 0.74) was found in FEV1% between
participants in the exercise programme (groups 0 +
1) and non-participants (group 2). Similarly, there
was no significant difference ( p =0.55) between par-
ticipants completing the exercise programme (group
1) and non-participants (group 2).
Primary outcomes
Exercise capacity
As seen in Table 4 and Figure 1, patients in group 1
significantly improved their VO2max, and their
VO2max/kg improved, though not significantly.
Quality of life
In group 1 a significant increase was found in the
domain of treatment burden from the scores before
the intervention (M= 64.39; SD= 13.20) to the post-
intervention scores (M = 76.19; SD= 8.56) p =0.013;
and in the domain of emotional functioning from the
scores before the intervention (M= 81.43; SD =
17.77) to the postintervention scores (M =86.19;
SD = 13.70) p = 0.021 (Table 5). The eta-squared
statistic (emotional functioning = 0.30; treatment
burden = 0.50) indicated a large effect size. No signifi-
cant differences were found in any other domains.
The CFQ-R 14+ scores of group 1 before the exer-
cise programme were compared with the CFQ-R 14+
scores of group 0 (drop-outs) before the exercise pro-
gramme and with the CFQ-R 14+ scores of group
2. No differences were found in any of the
comparisons.
The internal consistency of each scale showed
Cronbach’s α coefficients ranging from 0.42 to 0.92
with coefficients <0.70 in the domains of role limit-
ations (0.67); body image (0.62); social functioning
(0.43); and digestive symptoms (0.42).
Secondary outcomes
Anthropometric data
We found no significant differences in BMI z scores
(Table 4).
Lung function
We found no significant differences in FEV1%
(Table 4).
DISCUSSION
To our knowledge, this is the first study in patients
with CF investigating the response to an individually
tailored and unsupervised aerobic exercise pro-
gramme involving use of HR monitors. As far as we
TABLE 1 Clinical characteristics of the 24 patients entering the
exercise programme (groups 0+ 1).
N2 4
Gender M/F 15/9
Age range, years (median) 14–40 (19)
Genotype
ΔF508/ΔF508 17 patients
ΔF508/other mutations 7 patients
TABLE 2 Comparison of physical baseline data between patients completing the exercise programme (group 1) and dropouts (group
0); median (25; 75% percentiles).
Group 1 n = 14 Group 0 n=1 0 p-value
FEV1% 89.4 (76.8;105.4) 92.8 (82.9;109.1) 0.447
BMI z score −0.34 (−0.87;0.43) 0.01(−0.87;0.90) 0.520
VO2max (L/min) 2.40 (1.93;2.78) 2.39 (2.18;3.12) 0.520
VO2max/kg (mL/min/kg) 40.5 (34.5;45.8) 45.5 (36.8;47.0) 0.412
Age (years) 19 (15.5;27.0) 17 (15.5;19.5) 0.203
Gender 8M/6F 7M/3F 0.521
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measured by CFQ-R 14+ are primary outcomes.
Our study also included QoL and FEV1% analysis of
patients not participating in the exercise programme
(group 2).
We did not find a significant difference in FEV1%
between participants in the exercise programme
(group 0 +1) and non-participants (group 2). This
may indicate that the patient’s lung function did not
seem to play any role in the willingness to participate
in this study. Our individually tailored and unsuper-
vised exercise programme had no positive or negative
effect on FEV1%. The expected decline in lung func-
tion in patients with CF is likely to be between 2% and
3% annually. This suggests that studies shorter than
12 months may be unable to detect any difference in
lung function (Orenstein and Higgins, 2005). Conse-
quently, our study was not able to detect any effect on
lung function.
We showed that patients with CF with a relatively
good lung function (FEV1% above 60%) can in-
crease their VO2max significantly by participating in
a 12-week individually tailored and unsupervised
aerobic exercise programme. Our results are consist-
ent with the results of other studies in both children
and adults. Klijn et al (2004) found a significant
change in VO2max but not in VO2max/kg following a
12-week anaerobic exercise programme in children
with CF.
TABLE 3 Comparison of baseline FEV1% between patients
entering the exercise programme (groups 0+ 1), patients
completing the exercise programme (group 1) and patients
only filling in the CFQ-R 14+ (group 2).
FEV1%; median (25:75%)
Group 0+ 1 n =24 91.7 (79.7;106.3)
Group 1 n= 14 89.4 (76.8;105.4)
Group 2 n= 14 96.9 (79.6;104.1)
TABLE 4 Comparison of physical data of patients completing
the exercise programme (group 1) before and after the



















40.5 (34.5;45.8) 42.5 (35.0;48.0) 0.057
(∗) One patient did not complete the posttest on lung function
because of cough.
FIGURE 1 Patients above the diagonal improved their
VO2max.
TABLE 5 Quality of life in patients completing the exercise
programme (group 1) before and after the intervention.







90.8 ± 14.5 93.8 ±8.1 0.346
Role limitations 91.1 ± 12.0 92.9 ±7.9 0.566
Vitality 59.5 ± 16.6 64.9 ±11.4 0.204
Emotional
functioning
81.4 ± 17.8 86.2 ±13.7 0.021
Social functioning 74.6 ± 12.3 80.2 ±13.6 0.191
Body image 83.3 ± 16.2 82.5 ±14.9 0.783
Eating
disturbances
94.4 ± 12.1 93.7 ±15.5 0.655
Treatment
burden
64.3 ± 13.2 76.2 ±8.6 0.013
Health
perceptions
66.7 ± 20.4 73.8 ±17.2 0.091
Weight problems 83.3 ± 25.3 78.6 ±24.8 0.317
Respiratory
symptoms
77.8 ± 12.7 76.2 ±13.5 0.371
Digestive
symptoms
78.6 ± 19.7 80.2 ±17.0 0.496
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kg. This is in contrast to several studies (de Jong et al,
1994; Gulmans et al, 1999; Hebestreit et al, 2010; Sel-
vadurai et al, 2002; Turchetta et al, 2004). However, it
is worth mentioning that these studies had different
designs concerning type of intervention (e.g., aerobic
exercise, anaerobic exercise, or a combination of
these); the nature of the exercise (e.g., intensity, fre-
quency, and duration); age of study population; dur-
ation of study; and outcome measurements.
Our study showed that 30 minutes of unsupervised
exercise three times a week with an intensity of 70% of
the maximum HR was enough to increase VO2max.
Still, half of our patients did not manage to adhere
to this exercise programme for an extended period of
time. We expected that adherence in our study
would be better than other studies on unsupervised
exercise programmes because our patients could
choose between different activities, knowing that ad-
herence would never be as good as in supervised exer-
cise studies. We still chose to have unsupervised
exercise in our study to make it as realistic as possible.
We believe that it is not realistic for logistical, finan-
cial, and geographical reasons that patients attend all
exercise sessions supervised in the hospital. Our
study underlines that HR monitors are preferred in
unsupervised studies rather than exercise diaries
because they are often poorly updated and seldom re-
turned (Orenstein and Higgins, 2005). The HR moni-
tors gave an impression of whether the patients
exercised as instructed. Moreover, some of the
patients told us that the HR monitor was a motivating
factor. Apart from our study being unsupervised, the
reason for the high dropout rate in our study may be
the lack of emphasis on exercise as a part of routine
CF treatment in Denmark.
Many participants complained about lackof time to
do exercise but no one complained about the inten-
sity. This is interesting in the light of our results on fre-
quency, duration, and intensity. Engagement in
vigorous activities in patients completing the exercise
programme (group 1) did, on average, not meet the
intended frequency and duration. However, the inten-
sity of the lowest and the highest exercising patient was
between 75% of maximum HR on average and 86% of
maximum HR on average, both patients exercising
with an intensity considerably higher than the rec-
ommended 70% of maximum HR. This suggested
that the recommended intensity on 70% of
maximum HR was not the reason for the high
dropout level in our study. It can be debated
whether the intensity was individualised. The intensity
in relative terms was the same for all patients, whereas
the absolute intensity was based on maximum HR of
each patient. It may be that motivation, adherence,
and QoL could increase as intensity increased and
the duration of the exercise decreased.
The participation in our study was based on the
patient’s willingness, and we thus expected that all
participating patients were motivated. This study did
not allow patients to be randomised into a control
group (no exercise) and participants were informed
about this. At our CF Centre we encourage patients
to gradually take responsibility of their disease when
they become adolescents. We try to engage patients
through continuous (educational) dialogue regarding
treatment to enable the patient to take ownership of
their treatment. Our belief is that we can achieve
more by voluntariness of our patients and by their
inner motivation. We had hoped that an increase in
VO2max would increase QoL and thereby the inner
motivation to do exercise. A study by Arias Llorente,
Bousoño Garcìa, and Dìaz Martìn (2008) concluded
that adherence has shown to improve with treatments
that are perceived by patients as more important or in-
fluencing their QoL to a greater extent. Approxi-
mately 50% of people with chronic conditions do
not adhere to treatment, and adherence reduces
with the complexity of treatment. Previous studies in
CF have found that adherence to chest physiotherapy
and exercise is lower than other treatments
(Myers, 2009).
Despite the proven benefits of exercise, the degree
of physical activity generally undertaken in the CF
population remains an issue of concern. The develop-
ment of positive attitudes toward and a regular sche-
dule for activity early in life may be important in
determining an active style into adulthood (Prasad
and Cerny, 2002). Earlier studies reported reasonable
levels of compliance with exercise regimes. There are
numerous possible reasons for the improved rates of
adherence reported by these studies (e.g., the nature
of activity, individualised programs, and whether
activity is supervised). Programmes involving a single
activity especially if prescribed over long periods of
time are associated with poor long-term adherence
(Prasad and Cerny, 2002).
Our patients were offered supervised training at the
CF Centre once every second week but no patients ac-
cepted this offer. We made motivational phone calls to
all patients every week in the beginning of the exercise
programme and subsequent follow-up was planned
individually. Nearly all the patients had one super-
vised exercise session during the intervention. Our
strategy was to improve adherence by regular contact
between us and the patient, not to supervise the pro-
gramme as such but simply to show interest, enquire
about the patient’s well-being, and allow any queries
to be answered. This method has been used previously
as a part of an overall strategy to improve compliance
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(2000). This study reported good rates of adherence.
We assumed that the short intervention period and
individually tailored programme based on willingness
to participate could lead to a relatively high adherence.
However, several factors may influence adherence to
any treatment regime, including a patient’s willingness
to participate in regular exercise over a period of time.
These can be factors related to the disease process
itself, gender, age, and external factors such as social
support, perception of competency, self-esteem, en-
joyment of activity, and factors associated with the
patient’s behaviour such as motivation and choice
(Prasad and Cerny, 2002). The reason for the high
dropout rate in this study could be the subject of
further interest.
Our study failed to show that increased exercise
capacity expressed as VO2max could improve QoL.
We found a statistically significant increase in scores
of the domain of treatment burden and emotional
functioning. The magnitude of the differences in the
means were very large (eta-squared in treatment
burden = 0.50; emotional functioning =0.30). The
increase in the scores of the domain of treatment
burden was surprising. The explanation might be
that the patients did not see the exercise program as
a treatment burden, and the exercise program might
have made them feel more energetic though this was
not reflected in other domains such as vitality.
Change of behaviour starts as a mental process, and
this study indicated that changes did occur in patients
who completed the exercise programme (group 1) by
an improved emotional function score.
In this study the internal consistency of the CFQ-R
14+ scales measured by Chronbach’s α failed to reach
the recommended 0.7 in four of the scales. Three of
these scales also showed a weak internal consistency
in the validation of the CFQ-R + 14; the fourth scale
(role limitation) only showed a slightly lower Chron-
bach’s α (0.67) than recommended.
The fact that the questionnaire failed to show an
overall improvement in QoL might be explained by
the complexity of the CFQ-R 14+. Retrospectively,
we could not expect improvements in QoL after a
12-week intervention within the physical domains in
CFQ-R 14+ such as eating disturbances and weight
problems. Furthermore, group 1 had a high score in
several of the physical domains in the pretest, leaving
little room for improvement. The CFQ-R 14+ con-
sists of 49 self-reported items within 12 domains,
and the tool might have been too complex to show
whether increased exercise capacity could result in
increased QoL for patients with CF.
Two previous studies (Hebestreit et al, 2010; Klijn
et al, 2004) on exercise have used CFQ to evaluate
QoL, but not as a primary outcome. In contrast to
our study, Klijn et al (2004) included anaerobic train-
ing. The intervention period was similar to ours, but
this study was supervised. Klijn et al (2004) found a
significantly higher score in the domain of physical
function, but no change was found in other
domains. Recently, in a partially supervised exercise
programme for at least 6 months, Hebestreit et al
(2010) did not find any significant effect on QoL
except for the scale “Subjective Health Perception.”
Other intervention studies on exercise have
measured QoL as a secondary outcome but with
different measurements. In terms of degree of limit-
ation in activities of daily living (ADL), de Jong et al
(1994) found a decrease in the limitations in ADL.
Using the “Quality of Well-Being Scale” Orenstein
et al (2004) did not find any significant changes in
QoL, but Selvadurai et al (2002) showed a significant
difference in the aerobic exercise group. Earlier
Orenstein, Nixon, Ross, and Kaplan (1989) assessed
the “Quality of Well-Being Scale” and found a
correlation between this scale and peak oxygen con-
sumption. Gulmans et al (1999) found a significant
improvement for the Total Competence Score as
well as for the subscales “physical appearance” and
“general self-worth” using the “Self Perception
Profile for Children.” In summary, earlier studies
have not provided a precise picture of the connection
between exercise and QoL. Our study was not suc-
cessful in fully clarifying this either.
There are some limitations of this study to be
addressed. First, a 12-week study is a short time for
a lifestyle change in patients with a chronic disease
such as CF. Our aim was to increase exercise capacity
and investigate if it had any positive effect on QoL.
Bearing in mind that earlier studies have shown
significant changes in either VO2max or VO2max/kg in
12 or less than 12 weeks of exercise (de Jong et al,
1994; Klijn et al, 2004; Selvadurai et al, 2002;
Turchetta et al, 2004), we assessed that 12 weeks
would beenoughtoincreaseVO2max and thereby hope-
fully QoL. However, 12 weeks might not be enough to
increase QoL even though it is enough to increase
VO2max, and it could be interesting to study whether
a longer study period would make a difference.
Second, our patients did not on average exercise at
the recommended frequency and duration; instead,
they exercised with a higher intensity than rec-
ommended. We do not know if the influence on
QoL would have been different if our patients had ex-
ercised as recommended. Yet, the effect of the exercise
programme was still in favor of the intervention and
caused the expected increase in VO2max.
Third, in our exercise test we applied stepwise
increments with fixed increment of 0.4 kp in
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that some laboratories use continuous load increase
to avoid one heavy load at one occasion. Stepwise in-
crements could possibly cause some patients to finish
the exercise test too early. However, in the present
study all peak oxygen uptake measurements fulfilled
three of four criteria (total exhaustion, HR above
(220 - age) - 10%, respiratory exchanges ratio above
1.11, and/or the VO2 curve levelled off).
Fourth, the high dropout rate and thereby small
sample size have weakened the conclusions.
However, this has shown that the degree of encourage-
ment and supervision in this programme may not have
been sufficient and has to be individualised to achieve
adherence to exercise as part of CF treatment.
Finally, due to lack of follow-up, we do not know if
the patients in group 1 obtained a lifestyle change at
the end of the study period. Hebestreit et al (2010)
showed that at least 6 months of a partially supervised
and individualised physical activity programme might
be sufficient to cause persisting changes in activity be-
haviour and health. Whether our study is enough to
induce this persisting change is unknown. A follow-
up period in our study could have clarified this
because a lasting effect after 12 weeks would be clini-
cally relevant because such a programme can be
realised relatively easily. Our aim was to measure the
immediate effect of an unsupervised and individua-
lised 12-week exercise programme on VO2max and
QoL, and our study was not designed as a follow-up
study due to resources.
In conclusion, this study has shown that an effect
on VO2max can be achieved with an individually tai-
lored and unsupervised aerobic exercise programme
using HR monitors. A frequently postulated benefit
of any physical exercise is an enhanced feeling of
well-being. Thus, it was hypothesised that exercise
capacity would be related to QoL in patients with
CF. Improvement in QoL could not be demonstrated
in this study.
Regular exercise is a very important factor in main-
taining good health. This is even more important in
patients with chronic diseases such as CF. Therefore,
we still recommend that patients with CF increase or
maintain as good a physical fitness as possible.
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